Exacerbating Guillain–Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination
Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported. Exacerbation of Guillain–Barré syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. The patient is a 32-year-old male who dev...
Main Author: | Josef Finsterer |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2021/3619131 |
Similar Items
-
Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2021-01-01) -
Guillain-Barre syndrome in 220 patients with COVID-19
by: Josef Finsterer, et al.
Published: (2021-05-01) -
Post Covid-19 guillain barre syndrome
by: Boby Varkey Maramattom, et al.
Published: (2021-01-01) -
A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine
by: Shiavax J. Rao, et al.
Published: (2021-09-01) -
A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination
by: Yash Kripalani, et al.
Published: (2021-09-01)